4.6 Article

Degradation of hydroxyapatite in vivo and in vitro requires osteoclastic sodium-bicarbonate co-transporter NBCn1

Journal

MATRIX BIOLOGY
Volume 29, Issue 4, Pages 287-294

Publisher

ELSEVIER
DOI: 10.1016/j.matbio.2010.01.003

Keywords

Bone resorption; Bicarbonate transport; NBCn1; SLC4A7; shRNA

Funding

  1. Turku Graduate School for Biomedical Sciences (TUBS)
  2. Scandinavian Membrane Transport Network (MTP-Net)
  3. Ministry of Education, Science, and Technology, Korea [R01-2007-000-20441-0, 20090081952]
  4. Academy of Finland [116307]
  5. National Research Foundation of Korea [2010-50304, R01-2007-000-20441-0, 2007-0055802] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
  6. Academy of Finland (AKA) [116307, 116307] Funding Source: Academy of Finland (AKA)

Ask authors/readers for more resources

Dissolution of the inorganic bone matrix releases not only calcium and phosphate ions, but also bicarbonate. Electroneutral sodium-bicarbonate co-transporter (NBCn1) is expressed in inactive osteoclasts, but its physiological role in bone resorption has remained unknown. We show here that NBCn1, encoded by the SLC4A7 gene, is directly involved in bone resorption. NBCn1 protein was specifically found at the bone-facing ruffled border areas, and metabolic acidosis increased NBCn1 expression in rats in vivo. In human hematopoietic stem cell cultures, NBCn1 mRNA expression was observed only after formation of resorbing osteoclasts. To further confirm the critical role of NBCn1 during bone resorption, human hematopoietic stem cells were transduced with SLC4A7 shRNA lentiviral particles. Downregulation of NBCn1 both on mRNA and protein level by lentiviral shRNAs significantly inhibited bone resorption and increased intracellular acidification in osteoclasts. The lentiviral particles did not impair osteoclast survival, or differentiation of the hematopoietic or mesenchymal precursor cells into osteoclasts or osteoblasts in vitro. Inhibition of NBCn1 activity may thus provide a new way to regulate osteoclast activity during pathological bone resorption. (C) 2010 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available